CGON CGON R2K
$62.29
+143.13% 1Y
Market & Price
Market Cap
-
Current Price
$62.29
High / Low (52W)
$74.00 / $23.94
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-25.08%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-0.71
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$791.59M
Current Assets
$759.48M
Working Capital
$728.64M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
176.56%
Profit 5Y
-118.08%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- Compounding revenue at 176.6% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -118.1% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 194.00K | 0 | 9.00K | 529.00K | 111.00K | - | 52.00K | 0 | 1.67M | 2.32M | 1.08M |
| Cost of Revenue | - | - | - | - | - | 0 | 0 | - | 1.58M | 3.07M | 2.96M |
| Gross Profit | - | - | - | - | - | 43.00K | 52.00K | - | 89.00K | -748.00K | -1.88M |
| Operating Expenses | - | - | - | - | - | - | 42.26M | 48.74M | 51.22M | 47.95M | 64.51M |
| Operating Income | -9.72M | -12.33M | -14.04M | -22.47M | -25.85M | - | -42.20M | -48.74M | -51.13M | -48.70M | -66.39M |
| EBITDA | - | - | - | - | - | - | -42.18M | -48.59M | -50.71M | -47.85M | -65.55M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | -34.45M | -41.43M | -43.81M | -41.31M | -60.20M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -8.67M | -11.61M | -11.77M | -16.93M | -18.90M | - | -34.45M | -41.43M | -43.81M | -41.31M | -60.20M |
| Diluted EPS | -3.22 | -3.93 | -4.00 | -0.36 | -0.28 | -0.30 | -0.45 | -0.54 | -0.57 | - | -0.71 |
| R&D Expense | 7.84M | 9.83M | 11.73M | 17.21M | 18.47M | 19.62M | 27.47M | 31.33M | 27.88M | - | 43.73M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 191.00K | 204.00K | 1.14M | 4.04M |
| Cost of Revenue | - | - | 0 | 0 | 4.65M |
| Gross Profit | - | - | 204.00K | 1.14M | -607.00K |
| Operating Expenses | - | 35.44M | 55.65M | 115.81M | 190.17M |
| Operating Income | - | -35.25M | -55.45M | -114.67M | -190.77M |
| EBITDA | - | -35.23M | -55.43M | -114.63M | -189.33M |
| Interest Expense | 451.00K | 1.00K | - | - | - |
| Pretax Income | - | -35.44M | -48.61M | -88.04M | -161.00M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -35.44M | -48.61M | -88.04M | -161.00M |
| Diluted EPS | -0.55 | -11.71 | -15.65 | -1.41 | - |
| R&D Expense | - | - | 45.75M | 82.10M | 116.64M |
Compounded Sales Growth
| 5 Years: | 176.56% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -118.08% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +143.13% |
| 6 Months: | +36.87% |
| 3 Months: | +5.94% |
| 1 Month: | -3.80% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 147.75M | 199.30M | 754.80M | 791.59M |
| Current Assets | - | 147.21M | 194.12M | 754.21M | 759.48M |
| Cash & Equivalents | - | 88.14M | 8.27M | 257.07M | 32.49M |
| Inventory | - | - | - | 0 | 1.56M |
| Receivables | - | - | - | 0 | 688.00K |
| Total Liabilities | - | 22.57M | 14.51M | 21.42M | 38.99M |
| Current Liabilities | - | 15.43M | 14.25M | 21.37M | 30.84M |
| Long Term Debt | 12.06M | 6.53M | - | - | 3.00M |
| Total Debt | - | 15.94M | 461.00K | 238.00K | 7.02M |
| Total Equity | - | 125.18M | 184.79M | 733.38M | 752.60M |
| Shares Outstanding | - | 63.48M | 63.48M | 76.15M | 80.69M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -29.80M | -45.68M | -78.71M | -132.35M |
| Investing Cash Flow | - | -55.35M | -121.19M | -300.76M | -245.82M |
| Financing Cash Flow | - | 119.69M | 87.00M | 628.28M | 153.59M |
| Capital Expenditure | -97.00K | -14.00K | - | -234.00K | -134.00K |
| Free Cash Flow | - | -29.82M | -45.68M | -78.95M | -132.48M |
| Net Change in Cash | - | 34.54M | -79.88M | 248.80M | -224.58M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | 100.0% | 100.0% | -15.0% |
| Operating Margin % | - | -18,453.4% | -27,180.9% | -10,067.3% | -4,722.1% |
| Net Margin % | - | -18,556.5% | -23,827.0% | -7,729.5% | -3,985.0% |
| ROE % | - | -28.3% | -26.3% | -12.0% | -21.4% |
| ROCE % | - | -26.6% | -30.0% | -15.6% | -25.1% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CGON
No recent headlines available.